Roberto Mota
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
-
- Advanced Glycation End Products research
Papers in
-
- Muscle Physiology and Disorders 3
- Signaling Pathways in Disease 1
-
- Atherosclerosis and Cardiovascular Diseases 4
- Galectins and Cancer Biology 1
- Co-authors
- Edward Moreira Bahnson (3 shared papers)Monte S. Willis (3 shared papers)Traci L. Parry (2 shared papers)Ju Youn Beak (1 shared paper)Ralph B. D’Agostino (1 shared paper)David Brown (1 shared paper)Wei Huang (1 shared paper)Melissa C. Caughey (1 shared paper)
- Journals
- Current Pathobiology Reports (3 papers)American Journal Of Pathology (2 papers)The FASEB Journal (2 papers)Circulation Heart Failure (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Roberto Mota
15 papers receiving 233 citations
Peers
Comparison fields: 5 of 62
- Cardiology and Cardiovascular Medicine 88
- Clinical Biochemistry 12
- Biophysics 10
- Internal Medicine 6
- Physiology 7
Countries citing papers authored by Roberto Mota
This map shows the geographic impact of Roberto Mota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Mota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Mota more than expected).
Fields of papers citing papers by Roberto Mota
This network shows the impact of papers produced by Roberto Mota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Mota. The network helps show where Roberto Mota may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Mota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 92 | |
| 2 | 2020 | 43 | |
| 3 | 2024 | 28 | |
| 4 | 2020 | 20 | |
| 5 | 2018 | 16 | |
| 6 | 2018 | 9 | |
| 7 | 2018 | 7 | |
| 8 | 2021 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2025 | 0 |
About Roberto Mota
Roberto Mota is a scholar working on Molecular Biology, Immunology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 16 papers that have together received 233 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (4 papers), Protease and Inhibitor Mechanisms (3 papers), Muscle Physiology and Disorders (3 papers), Advanced Glycation End Products research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Cancer Treatment and Pharmacology (1 paper), Signaling Pathways in Disease (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (88 citations), Clinical Biochemistry (12 citations), Biophysics (10 citations), Internal Medicine (6 citations) and Physiology (7 citations). Roberto Mota has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Edward Moreira Bahnson, Monte S. Willis, Traci L. Parry, Ju Youn Beak, Ralph B. D’Agostino, David Brown, Wei Huang, Melissa C. Caughey, W. Gregory Hundley and Jennifer H. Jordan. Their work appears in journals such as Current Pathobiology Reports, American Journal Of Pathology, The FASEB Journal, Circulation Heart Failure and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.